Prolia 60 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FZ9W0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,702
Award facts
- Contract value 100% obligated
- $43,702.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $43,702.03 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/mL syringes. This competitively awarded, firm fixed-price contract with an ultimate completion date of November 4, 2025, represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order carries no set-aside designation, reflecting the contractor's competitive qualification to meet federal pharmaceutical procurement standards. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving military and veteran healthcare systems through an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company maintains a $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling deliveries across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific Prolia delivery order exemplifies AmerisourceBergen's role as a primary supplier within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FZ9W0?
SPE2DR26FZ9W0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FZ9W0 worth?
The government has obligated $43,702 on SPE2DR26FZ9W0.
Is contract SPE2DR26FZ9W0 an order under another contract?
Yes. SPE2DR26FZ9W0 is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FZ9W0 competed?
The extent of competition for SPE2DR26FZ9W0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award